Januvia May Cause Pancreatic Cancer and Death, Lawsuits Allege

December 18, 2013

Important Information

ClassAction.org is no longer reviewing claims for this case. The information here is for reference only. Up-to-date information and resources can be found here.

Comments |

At A Glance

This Alert Affects
Those who were diagnosed with pancreatic cancer after taking Januvia (sitagliptin) or Janumet (sitagliptin/metformin).
What Is Januvia?
Januvia is used to treat type 2 diabetes and belongs to a group of drugs known as incretin mimetics. It is also available as a combination drug, known as Janumet, which contains both Januvia and another type 2 diabetes drug, metformin.
Side Effects
Pancreatitis, pancreatic cancer and death.
Manufacturer
Merck & Co., Inc.
Type of Lawsuit
Mass Tort